[Asia Economy Reporter Kum Bo-ryeong] Naivek recorded the daily upper limit on the 21st following news that it signed material supply agreements with six multinational pharmaceutical companies at the world's largest international bio-healthcare conference.
According to the Korea Exchange, as of 3:14 PM that day, Naivek was trading at 13,150 KRW, up 29.56% (3,000 KRW) from the previous day.
At the 'JP Morgan Healthcare Conference,' Naivek signed material transfer agreements (MTA) and confidentiality agreements (CDA) with six multinational pharmaceutical companies regarding its anticancer drug and peptide platform (NIPEP-TPP) applied to anticancer treatment.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
